Adults and elderly
The usual dose is up to 80 mmol (millimoles) per day. The medication will be prepared with a concentration of 20-40 mmol/liter.
Use in children and adolescents
The usual dose is up to 3 mmol (millimoles) per kilogram of body weight and per day. The medication will be prepared with a concentration of 20 mmol/liter. For children weighing 25 kg or more, consult the adult dose.
If you use more Potassium Chloride Serraclinics than you should
This medication will generally be administered to you by a doctor or a nurse. If you think you may have received too much medication, please inform your doctor or nurse immediately.
Too much potassium in your blood can cause severe adverse effects that may put your life at risk.
Please read carefully the important warning at the beginning of the next section, Section 4, about the signs that would allow you to detect that you have too much potassium in your blood.
If you forgot to use Potassium Chloride Serraclinics
This medication will generally be administered to you by a doctor or a nurse. If you think they may have forgotten to administer a dose, please inform your doctor or nurse.
If you have any other questions about the use of this medication, ask your doctor or pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everyone will experience them. The expected benefit of the medicine will generally be greater than the risk of you experiencing a harmful side effect.
Important: Side effects or symptoms to be aware of, and what to do if you are affected. The first signs of high potassium levels in your blood are: irregular heartbeats, chest pain, possible heart attack, muscle weakness, paralysis, or difficulty breathing. If you experience any of these symptoms, seek urgent medical attention.
In some people, the following other side effects may occur:
Immune system problems:
·Fever.
Heart and circulation problems:
·Low blood pressure (you may feel dizzy)
Problems at the injection site:
·Pain, redness, irritation, and swelling at the injection site
Nervous system problems:
·Needles or pins and needles in the hands or feet
·Flaccid paralysis of the muscles
·Loss of reflexes
·Weakness, lack of energy
·Mental confusion
·Weakness and heaviness in the legs
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly to theSpanish System for Pharmacovigilance of Medicines for Human Use:www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Do not use this medication after the expiration date that appears on the packaging after “CAD”. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Use your medication only if it is a transparent and colorless liquid. Open and use it immediately. The product must be diluted and used immediately after opening. Any unused portion must be discarded.
Medicines should not be disposed of through drains or in the trash.Ask your pharmacisthow to dispose ofthepackaging and of themedicines that you no longerneed.. This will help protect the environment.
-The active ingredient is potassium chloride.
-The other components are: water for injection preparations.
The medicine contains 15% w/v (150 mg per ml) of potassium chloride. Each ml (milliliter) of this medicine contains 2 mmol of potassium and 2 mmol of chloride.
Product Appearance and Packaging Content
Potassium Chloride Serraclinic is a concentrate for solution for infusion. This means it is a concentrated (strong) solution in a plastic container. It is a transparent and colorless liquid. The potassium chloride must be diluted before use at least with 50 times its volume of an appropriate diluent. More liquid must be added to the solution (diluted) to prepare a less concentrated solution that can be administered by infusion (infusion).
Each plastic ampoule contains 5 ml (milliliters), 10 ml, or 20 ml of the medicine. In a box, there are 20 ampoules. Some sizes of packaging may only be commercially available.
Holder of the Marketing Authorization and Responsible for Manufacturing
Holder of the Marketing Authorization
Laboratorios SERRA PAMIES S.A.
Ctra. Castellvell, 24
43206 REUS (Tarragona)
Responsible for Manufacturing
Demo S.A.
21st Km National Road Athens-Lamia
14568 Athens
Greece
This medicine is authorized in the member states of the European Economic Area with the following names:
AT: Kaliumchlorid Noridem 15% Concentrate for the Preparation of an Infusion Solution
BE: POTASSIUM CHLORIDE NORIDEM 15% (w/v) Solution to be Diluted for Infusion
DE: Kaliumchlorid Noridem 150mg/mL Concentrate for the Preparation of an Infusion Solution
DK: Kaliumchlorid “Noridem”, Concentrate for Infusion Fluid, Solution 2mmol/mL
EL: POTASSIUM CHLORIDE 15%/NORIDEM,?????d????µa??apa?as?e??d?a??µat??p???????s?150mg/mL
ES:Potassium Chloride SERRACLINIC 2 mEq/ml, Concentrate for Solution for Infusion
IE: Potassium Chloride 15% (w/v) Concentrate for Solution for Infusion
NL: Kaliumchloride Noridem 15% (w/v) Concentrate for Solution for Infusion
NO: Kaliumklorid 2mmol/mL Concentrate for Infusion Fluid "Noridem"
PT: Potassium Chloride Noridem 150 mg/ml Concentrate for Solution for Infusion
SE: Kaliumklorid Noridem 2mmol/mL Concentrate for Infusion Fluid, Solution
UK: Potassium Chloride 15% (w/v) Concentrate for Solution for Infusion
Last Review Date of this Leaflet: 10/10/2016.
The detailed and updated information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.